Skip to main content

Reasons for choice of glaucoma surgery in eyes not treated with anti-glaucoma medications

Abstract

Background

In the real world, some glaucoma patients can undergo an incisional glaucoma surgery without using medication. The rate of cases with no medication treatment at the time of surgery among those that underwent incisional glaucoma surgeries performed in our department was reported.

Methods

The department database of Shimane University Hospital for eyes that underwent incisional surgeries to manage glaucoma at the hospital between April 2018 and September 2020 were searched. By reviewing the medical charts of 1,417 consecutive eyes listed, 90 (6.4%) eyes of 67 subjects (mean age of 72 ± 16 years; 22 men, 29 eyes; 45 women, 61 eyes) who underwent a surgery without use of antiglaucoma medication were identified. The types of glaucoma, glaucoma procedures, and reasons for choosing the glaucoma surgeries rather than medical therapy were collected for the 90 eyes.

Results

Among the 90 eyes, primary angle-closure disease (PACD) (60%) was the most frequent type of glaucoma followed by EXG (17%), POAG (16%), and others (8%). Among the reasons for the choice of incisional surgery, relief of angle closure (64%) was the most frequent, the second most frequent was the incidental diagnosis of glaucoma during the ocular examinations both for that eye’s cataract surgery or the contralateral glaucoma surgery (13%). Other reasons included poor medication adherence (10%), dementia (6%), multiple medication allergy (3%), and acute IOP elevation other than PACD (3%). Cataract extraction (CE) alone (33%) was the most frequent glaucoma procedures performed in these eyes, followed by CE combined with goniosynechialysis (27%), CE + iStent (16%), CE + goniotomy by Tanito microhook ab interno trabeculotomy or using the Kahook Dual Blade (11%), Ahmed Glaucoma valve implantation (11%), and trabeculectomy (2%).

Conclusion

In the real-world, 6.4% of incisional glaucoma surgeries were performed in the absence of medication use; of them, 32 eyes (2.3%) were with open angle glaucoma. In open angle glaucoma, the reasons can be classified into; 1) patients’ inability to instill the medication, 2) incidental diagnosis of glaucoma during the pre-surgical examinations, and 3) the eyes with acute IOP rise.

Peer Review reports

Introduction

The standard first-line treatment for ocular hypertension and open-angle glaucomas (OAG) such as primary OAG (POAG) and exfoliation glaucoma (EXG), is topical eye drops that decrease intraocular pressure (IOP). Incisional glaucoma surgeries generally are the options considered in patients using anti-glaucoma medications. In the real world, some patients can undergo an incisional surgery without using medication, although these data are difficult to assess in the literature. We report the rate of cases with no medication treatment at the time of surgery among those that underwent incisional glaucoma surgeries performed in our department over the past 2.5 years.

Subjects and methods

The study adhered to the tenets of the Declaration of Helsinki, and the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. The institutional review board of Shimane University Hospital approved the study (IRB No. 20200401–3), which did not require that each patient provide written informed consent; instead the protocol was posted at the study institution to notify participants about the study. We searched the department database of Shimane University Hospital for eyes that underwent incisional surgeries to manage glaucoma at the hospital between April 2018 and September 2020. The medical charts of 1,417 consecutive eyes listed were reviewed, and 90 (6.4%) eyes of 67 subjects who underwent a surgery without use of antiglaucoma medication were identified. The subjects for whom medications had been prescribed but who did not/could not use the medications and opted to undergo surgery also were included in the study. From the medical charts, the types of glaucoma, glaucoma procedures, and reasons for choosing the glaucoma surgeries rather than medical therapy were collected for the 90 eyes.

Results

Subjects (22 men, 29 eyes; 45 women, 61 eyes) were a mean ± standard deviation age of 72 ± 16 years (range, 14–94 years). Among the 90 eyes, primary angle-closure disease (PACD) (60%) was the most frequent type of glaucoma followed by EXG (17%), POAG (16%), and others (8%) (Table 1). Among the reasons for the choice of incisional surgery, relief of angle closure (64%) was the most frequent, the second most frequent was the incidental diagnosis of glaucoma during the ocular examinations both for that eye’s cataract surgery or the contralateral glaucoma surgery (13%). Other reasons included poor medication adherence (10%), dementia (6%), multiple medication allergy (3%), and acute IOP elevation other than PACD (3%) (Table 1). Cataract extraction (CE) alone (33%) was the most frequent glaucoma procedures performed in these eyes, followed by CE combined with goniosynechialysis (GSL) (27%), CE + iStent (Glaukos Corporation, San Clemente, CA) (16%), CE + goniotomy by Taito microhook ab interno trabeculotomy or using the Kahook Dual Blade (New World Medical, Inc., Rancho Cucamonga, CA) (11%), Ahmed Glaucoma valve implantation (New World Medical, Inc.) (11%), and trabeculectomy (2%) (Table 1). For 12 eyes received glaucoma surgery due to the incidental diagnosis of glaucoma during the ocular examinations both for that eye’s cataract surgery or the contralateral glaucoma surgery, CE + iStent (54%) was the most frequent glaucoma procedure, followed by CE + goniotomy (38%) (Table 1). For 17 eyes received glaucoma surgery due to poor medication adherence, dementia, or multiple medication allergy, CE + iStent (35%) and Ahmed Glaucoma Valve (35%) were the most frequent glaucoma procedures, followed by CE + goniotomy (23%), and trabeculectomy (6%) (Table 1). Three eyes that received glaucoma surgery due to acute IOP rises other than PACD were treated with trabeculectomy for Posner-Schlossman syndrome, Ahmed Glaucoma Valve for sarcoidosis, and CE (+ anterior vitrectomy) for lens induced uveitis (Table 1).

Table 1 Summary of 90 eyes treated with glaucoma surgery without use of antiglaucoma medication

Discussion

In our department, 6.4% of incisional glaucoma surgeries were performed in the absence of medication use or because of the patients’ inability to instill the medication. To our best knowledge, this information is unique in the literature. Based on the glaucoma type, the study eyes can be classified into two groups; the one group is PACD and the other group is open angle glaucoma. Based on the reasons for choice of surgery, most of the eyes in the latter group can be further classified into three groups; 1) the eyes of the patients with poor tolerance/adherence to medication therapy, 2) the eyes of the patients with incidental diagnosis of glaucoma during the pre-surgical examinations for cataract or opposite eye’s glaucoma surgery, and 3) the eyes with acute IOP rise that required immediate IOP lowering surgery such as secondary open angle glaucoma due to inflammation.

In this study, the most frequent types of glaucoma and surgical procedure were the PACD and CE alone, respectively. CE has been considered a first-line treatment in PACD [1], and the combination of GSL and CE may be more effective than CE alone for lowering IOP in PACD [2]. Accordingly, the high frequencies of relief of angle closure as the surgical indication and CE + GSL/CE alone as surgical procedures reflect the current treatment recommendations. The reasons for choice of CE alone, CE + GSL, or CE + minimally invasive glaucoma surgery (MIGS) would be interesting to know and is needed to be clarified in the future.

Previous studies have reported that poor medication adherence and drug-induced side effects, e.g., ocular surface diseases and drug allergy, were related to poor visual prognosis in glaucoma [3, 4]. Conditions associated with older age were anticipated to reduce medication adherence due to difficulty instilling eye drops (e.g., tremor), difficulty in accessing educational resources (e.g., lack of internet access), and reduced treatment motivation (e.g., dementia and depression) [5, 6]. In the current study, 17 eyes (19%) underwent glaucoma surgery due to poor adherence or intolerance to medication; these were the major reasons for glaucoma surgery in OAG. With this scenario, to provide adherence-independent reduction of IOP, filtration surgeries such as tube shunt surgery or trabeculectomy tended to be performed (Table 1).

Previous studies have reported that up to 90% of patients were unaware of their diagnosis when they were diagnosed [7, 8]. Accordingly, in subjects with cataract, glaucoma can be diagnosed initially during the surgical examinations before cataract surgery. In the same context, in subjects with unilateral glaucoma, glaucoma can be diagnosed initially in the contralateral eye during the surgical examinations before glaucoma surgery for the other eye. For this group of eyes, MIGS including use of the iStent and goniotomy were the choices of surgical procedures, (Table 1). MIGS have gained popularity because of the ease of performing them during CE, the safer profile than filtration surgeries, and effective reduction of the numbers of antiglaucoma medications needed [9,10,11]. Among the current cases, the incidentally identified glaucoma with visually significant cataract were all treated by MIGS + CE. Given the study site is the tertiary care hospital, and the patients refer from far and wide area. For such patients, especially for older patients, specialized glaucoma care is sometimes difficult to access in their local area. In Japan, many of the cataract surgery and most of the glaucoma surgery are done by hospitalizations. Accordingly, patients of this group likely choose primary glaucoma surgery because they saw the hospitalization as a good opportunity to receive specialized glaucoma treatment.

It is important to note that the data shown in this study and interpretation of data are strictly related to the country and region where the patients live, and the roles of hospital where the physicians work. Ethnic, social, and economic differences or factors should affect the data, too. Insufficiency/absence of the analyses between the relationships between surgical procedure/reasons for surgical choice and the background characteristics (i.e., age, sex, glaucoma stage and severity, etc.…) are the weak point of this study. However, we believe that the purpose of this study, that is, first to elucidate the rate of incisional glaucoma surgeries performed in the absence of medication use by entire number survey, is achieved.

Based on the vital statistics of the Japanese Government, the aging rate of the population 65 years old or older in Japan is the highest worldwide (http://www.cao.go.jp/en/whitepaper.html); therefore, we expect that the choice of glaucoma surgery rather than medication therapy due to age-related reduction in medication adherence is going to increase in the future in areas of the world where individuals will live to an advanced age.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available due to limitations of ethical approval involving the patient data and anonymity but are available from the corresponding author on reasonable request.

References

  1. Azuara-Blanco A, Burr J, Ramsay C, Cooper D, Foster PJ, Friedman DS, Scotland G, Javanbakht M, Cochrane C, Norrie J. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388(10052):1389–97.

    Article  Google Scholar 

  2. Young CEC, Seibold LK, Kahook MY. Cataract surgery and intraocular pressure in glaucoma. Curr Opin Ophthalmol. 2020;31(1):15–22.

    Article  Google Scholar 

  3. Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmology. 2003;110(4):726–33.

    Article  Google Scholar 

  4. Kaštelan S, Tomić M, Metež Soldo K, Salopek-Rabatić J. How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int. 2013;2013:696328.

    PubMed  PubMed Central  Google Scholar 

  5. Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2009;23(4):924–32.

    Article  CAS  Google Scholar 

  6. Yochim BP, Mueller AE, Kane KD, Kahook MY. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21(4):250–4.

    Article  Google Scholar 

  7. Waisbourd M, Pruzan NL, Johnson D, Ugorets A, Crews JE, Saaddine JB, Henderer JD, Hark LA, Katz LJ. The Philadelphia Glaucoma Detection and Treatment Project: Detection Rates and Initial Management. Ophthalmology. 2016;123(8):1667–74.

    Article  Google Scholar 

  8. Yamamoto T, Iwase A, Araie M, Suzuki Y, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, et al. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112(10):1661–9.

    Article  Google Scholar 

  9. Chen HY, Lin CL, Kao CH. Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study. Medicine (Baltimore). 2019;98(4):e14128.

    Article  Google Scholar 

  10. Fingeret M, Dickerson JE Jr. The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma. Optom Vis Sci. 2018;95(2):155–62.

    Article  Google Scholar 

  11. Tanito M, Matsuo M. Ab-interno trabeculotomy-related glaucoma surgeries. Taiwan J Ophthalmol. 2019;9(2):67–71.

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

KS and MT conceived and designed the trial. KS, HF, and TO reviewed patients’ medical records and collected the data. KS and MT interpreted the data. MT drafted the manuscript, and KS, HF, and TO approved the final version of the manuscript.

Corresponding author

Correspondence to Masaki Tanito.

Ethics declarations

Ethics approval and consent to participate

The study adhered to the tenets of the Declaration. of Helsinki, and the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. The institutional review board of Shimane University Hospital approved the study, which did not require that each patient provide written informed consent; instead the protocol was posted at the study institution to optout the participants from the study.

Consent for publication

Not applicable.

Competing interests

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugihara, K., Fukuda, H., Omura, T. et al. Reasons for choice of glaucoma surgery in eyes not treated with anti-glaucoma medications. BMC Ophthalmol 22, 145 (2022). https://doi.org/10.1186/s12886-022-02369-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-022-02369-z

Keywords